Focused-ultrasound developer InSightec has received approval from Health Canada for its ExAblate 2000 MR-guided focused ultrasound (MRgFUS) system.
The device was cleared for the treatment of symptomatic uterine fibroids, according to the Haifa, Israel-based firm.
By AuntMinnie.com staff writers
March 12, 2007
Related Reading
InSightec nets FDA clearance for new software, March 5, 2007
FDA clears InSightec's ExAblate 2000 for GE 3T MRI, March 1, 2007
InSightec raises $15 million, August 10, 2006
InSightec to bring Exablate to Australia, Taiwan, June 21, 2006
InSightec reports first North American MRgFUS patient, May 31, 2006
Copyright © 2007 AuntMinnie.com
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
